人工智能
虚拟筛选
计算机科学
药物发现
化学
数据科学
重新调整用途
机器学习
工程类
生物化学
废物管理
作者
Xin Yang,Yifei Wang,Ryan Byrne,Gisbert Schneider,Shengyong Yang
出处
期刊:Chemical Reviews
[American Chemical Society]
日期:2019-07-11
卷期号:119 (18): 10520-10594
被引量:665
标识
DOI:10.1021/acs.chemrev.8b00728
摘要
Artificial intelligence (AI), and, in particular, deep learning as a subcategory of AI, provides opportunities for the discovery and development of innovative drugs. Various machine learning approaches have recently (re)emerged, some of which may be considered instances of domain-specific AI which have been successfully employed for drug discovery and design. This review provides a comprehensive portrayal of these machine learning techniques and of their applications in medicinal chemistry. After introducing the basic principles, alongside some application notes, of the various machine learning algorithms, the current state-of-the art of AI-assisted pharmaceutical discovery is discussed, including applications in structure- and ligand-based virtual screening, de novo drug design, physicochemical and pharmacokinetic property prediction, drug repurposing, and related aspects. Finally, several challenges and limitations of the current methods are summarized, with a view to potential future directions for AI-assisted drug discovery and design.
科研通智能强力驱动
Strongly Powered by AbleSci AI